Influence of perineurial cells and Toll-like receptors 2 and 9 on Herpes simplex type 1 entry to the central nervous system in rat encephalitis.
Herpes simplex encephalitis (HSE) is a rare disease with high mortality and significant morbidity among survivors. We have previously shown that susceptibility to HSE was host-strain dependent, as severe, lethal HSE developed after injection of human Herpes simplex type 1 virus (HSV-1) into the whiskers area of DA rats, whereas PVG rats remained completely asymptomatic. In the present study we investigated the early immunokinetics in these strains to address the underlying molecular mechanisms for the observed difference. The virus distribution and the immunological responses were compared in the whiskers area, trigeminal ganglia and brain stem after 12 hours and the first four days following infection using immunohistochemistry and qRT-PCR. A conspicuous immunopathological finding was a strain-dependent difference in the spread of the HSV-1 virus to the trigeminal ganglia, only seen in DA rats already from 12 hpi. In the whiskers area infected perineurial cells were abundant in the susceptible DA strain after 2 dpi, whereas in the resistant PVG rats HSV-1 spread was confined only to the epineurium. In both strains activation of Iba1(+)/ED1(+) phagocytic cells followed the distribution pattern of HSV-1 staining, which was visible already at 12 hours after infection. Notably, in PVG rats higher mRNA expression of Toll-like receptors (Tlr) -2 and -9, together with increased staining for Iba1/ED1 was detected in the whiskers area. In contrast, all other Tlr-pathway markers were expressed at higher levels in the susceptible DA rats. Our data demonstrate the novel observation that genetically encoded properties of the host nerve and perineurial cells, recruitment of phagocyting cells together with the low expression of Tlr2 and -9 in the periphery define the susceptibility to HSV-1 entry into the nervous system.
Bereczky-Veress
Biborka
B
Department of Medicine Solna, Unit of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
Abdelmagid
Nada
N
Piehl
Fredrik
F
Bergström
Tomas
T
Olsson
Tomas
T
Sköldenberg
Birgit
B
Diez
Margarita
M
D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D002490:Central Nervous System / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D003713:Dendritic Cells / Q000276:immunology / Q000821:virology; D018792:Encephalitis, Viral / Q000276:immunology / Q000378:metabolism* / Q000821:virology; D005786:Gene Expression Regulation / Q000276:immunology; D018259:Herpesvirus 1, Human / Q000502:physiology*; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D018836:Inflammation Mediators / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology / Q000821:virology; D007700:Kinetics; D008264:Macrophages / Q000276:immunology / Q000821:virology; D008297:Male; D010525:Peripheral Nerves / Q000378:metabolism / Q000473:pathology* / Q000821:virology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D012583:Schwann Cells / Q000473:pathology / Q000821:virology; D015398:Signal Transduction / Q000276:immunology; D013045:Species Specificity; D013997:Time Factors; D051195:Toll-Like Receptor 2 / Q000378:metabolism*; D051217:Toll-Like Receptor 9 / Q000378:metabolism*; D012668:Trigeminal Ganglion / Q000473:pathology / Q000821:virology; D014738:Vibrissae / Q000294:innervation / Q000821:virology; D053586:Virus Internalization
D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D018836:Inflammation Mediators; D012333:RNA, Messenger; D051195:Toll-Like Receptor 2; D051217:Toll-Like Receptor 9
Lancet. 1984 Sep 29;2(8405):707-11
6148470
Front Biosci. 2008 May 01;13:4862-72
18508551
J Cereb Blood Flow Metab. 2010 Mar;30(3):603-15
19861972
J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21
12430718
J Neurol. 2006 Feb;253(2):163-70
16222428
Gen Cytochem Methods. 1958;1:399-422
13574437
Science. 2006 Oct 13;314(5797):308-12
16973841
Curr Opin Immunol. 2008 Aug;20(4):420-5
18625310
J Immunol. 2010 Jun 15;184(12):7010-21
20483728
Neuroscience. 2002;115(1):321-9
12401344
J Neurol. 2009 Aug;256(8):1243-51
19353228
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17343-8
17085599
J Gen Virol. 1990 Feb;71 ( Pt 2):405-10
2155294
J Cell Biol. 2007 Apr 23;177(2):265-75
17452530
J Immunol. 2006 Nov 15;177(10):7094-102
17082626
Science. 2007 Sep 14;317(5844):1522-7
17872438
Neuroscience. 1997 Nov;81(1):255-62
9300418
J Neurosci Methods. 1980 Dec;3(2):129-49
6110810
Blood. 2004 Feb 15;103(4):1433-7
14563635
Virology. 2010 May 10;400(2):248-58
20199790
J Virol. 2007 Oct;81(20):11128-38
17686871
J Neurovirol. 2008 Apr;14(2):102-18
18444082
J Neurocytol. 1984 Dec;13(6):923-34
6398831
Am J Pathol. 2005 May;166(5):1419-26
15855642
J Virol. 2003 Apr;77(8):4588-96
12663765
J Neuroimmunol. 2009 Aug 18;213(1-2):26-30
19564053
J Infect Dis. 1993 Nov;168(5):1248-52
8228358
J Immunol. 2008 Dec 15;181(12):8604-12
19050280
J Cell Sci. 2006 Oct 1;119(Pt 19):3981-93
16988027
Nature. 2005 Apr 7;434(7034):772-7
15800576
Am J Pathol. 1993 Aug;143(2):410-8
8102030
Glia. 2010 Nov 1;58(14):1701-9
20578041